Hemlibra Injection 150mg 1 vial

Quantity

Get it to United States within 10 working days with standard delivery.

Fast delivery to United States

Easy Returns & Exchanges

Ask About This Product

Condition : New

0

From UAE

To United States

in 5-10 days

Description

How it Works

Hemlibra (emicizumab) is a monoclonal antibody used to prevent bleeding episodes in individuals with hemophilia A. Hemophilia A is a genetic disorder caused by missing or defective factor VIII, a clotting protein. Hemlibra works by bridging activated factor IX and factor X to restore the function of the missing factor VIII, thereby helping the blood to clot normally. This innovative mechanism allows Hemlibra to provide effective prophylaxis for bleeding in patients with hemophilia A, reducing the frequency and severity of bleeding episodes.

Side Effects

  • Injection site reactions (e.g., redness, pain, swelling)
  • Headache
  • Joint pain (arthralgia)
  • Fever
  • Diarrhea
  • Thrombotic microangiopathy (rare)
  • Thrombosis (blood clots)
  • Nausea
  • Fatigue
  • Muscle pain (myalgia)

Indications

  • Prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency) with or without factor VIII inhibitors

Contraindications

  • Known hypersensitivity to emicizumab or any of its components
  • Active thrombotic conditions
  • Concurrent use of prothrombin complex concentrates (PCC) for extended periods
  • Severe allergic reactions (e.g., anaphylaxis)
  • Pregnancy and lactation (use with caution)

Price Comparison in Different Countries

Country Price (USD) Website
United States $6,500 GoodRx
Canada $5,800 PharmacyChecker
United Kingdom ?4,900 NHS
Australia AUD 8,500 PBS
India ?450,000 Medindia

Top 5 Global Brands

  1. Hemlibra (Roche)
  2. Eloctate (Sanofi)
  3. Advate (Takeda)
  4. Afstyla (CSL Behring)
  5. Jivi (Bayer)
 
Shopping Cart